Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of F5-peptide and/or P-gp inhibitor in preparation of cross-blood-testis barrier drug, oral targeting nanoparticle and drug

A nanoparticle and inhibitor technology, applied in the field of biopharmaceuticals, can solve problems such as limiting drug transport and limiting drug trans-barrier transport

Pending Publication Date: 2022-05-17
THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] BTB has a physical and biochemical barrier function that significantly limits drug delivery to the testis
First of all, although BTB provides a good microenvironment for spermatogenesis, it also restricts the diffusion and transport of water, electrolytes, ions, hormones, paracrine factors and other cell bypass and transcellular pathways, and also greatly limits the drug delivery. Transport across barriers, e.g., small hydrophilic drugs and macromolecular drugs that cannot easily diffuse across lipid bilayers (such as antibodies and antibody-drug conjugates), etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of F5-peptide and/or P-gp inhibitor in preparation of cross-blood-testis barrier drug, oral targeting nanoparticle and drug
  • Application of F5-peptide and/or P-gp inhibitor in preparation of cross-blood-testis barrier drug, oral targeting nanoparticle and drug
  • Application of F5-peptide and/or P-gp inhibitor in preparation of cross-blood-testis barrier drug, oral targeting nanoparticle and drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031]The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

[0032] Adjudin interferes with the process of spermatogenesis and its application limitations

[0033] Adjudin, also known as AF2364 (MW: 335.18), is a derivative of lonidamine, by affecting actin regulatory proteins (Eps8, Arp3, Palladin, Formin1, etc.) and microtubule regulatory proteins (CAMSAP2, EB1, MARK4, etc.) Expression and distribution in the seminiferous epithelium, so that actin and microtubules cannot be polymerized and depolymerized normally...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of F5-peptide and / or a P-gp inhibitor in preparation of a cross-blood-testis barrier drug, and oral targeting nanoparticles and a drug, and proposes that the physical barrier of BTB is destroyed by using F5-peptide and the biochemical barrier of BTB is destroyed by using Tariquilar to inhibit P-gp, so that BTB is instantaneously'open 'and'closed', and a basic ES protein and a tight junction protein are not tightly connected with BTB near a basement membrane any more, so that the BTB is not tightly connected with the BTB near the basement membrane. According to the present invention, the FAF5T-LAN oral targeting nano-preparation carrying the active Adjudin molecule is provided, the FAF5T-LAN oral targeting nano-preparation carrying the active Adjudin molecule is expected to become the high-compliance male contraceptive, and the important social significance and the important economic value are provided, such that the exogenous drug Adjudin cannot be pumped out of the BTB by the P-gp transport protein so as to smoothly transport the Adjudin to the spermatogenic epithelium;

Description

technical field [0001] The invention relates to the technical field of biopharmaceuticals, in particular to the application of F5-peptide and / or P-gp inhibitors in the preparation of drugs across the blood-testis barrier and the oral targeting of nanoparticles and drugs. Background technique [0002] The testicular seminiferous epithelium is the starting point of the spermatogenesis process, mainly composed of supporting cells connected to the basement membrane and a variety of germ cells, and a variety of intercellular connections between supporting cells constitute the blood-testis barrier (BTB). The presence of BTB prevents the transfer of harmful substances from the blood into the testicular seminiferous epithelium, but also prevents the transfer of most small and large molecule drugs (such as peptides, proteins and gene-based drugs). Studies have shown that BTB not only hinders the transport of drugs (such as contraceptives, antiviral drugs) in the seminiferous tubules,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61K9/51A61K47/24A61K47/36A61K48/00A61P15/16B82Y5/00B82Y40/00A61K31/4725A61K31/416
CPCA61K38/17A61K31/4725A61K31/416A61K48/005A61K48/0025A61K48/0075A61K9/5123A61K9/5161A61K9/0053A61P15/16B82Y5/00B82Y40/00A61K2300/00
Inventor 毛百萍林儒风上官王宁朱炫敬李超吴劲翰姚涛虞诗程胡恩德胡媚媚
Owner THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products